WHO: Fight Ebola Now, Solve Patent Issues Later 06/09/2014 by Catherine Saez, Intellectual Property Watch 2 Comments The world and the global health community have been taken by surprise by the worst outbreak of Ebola so far. The World Health Organization today (5 September) said a vaccine could be available in November 2014 if proven safe. So far, according to the WHO, intellectual property issues have not acted as a barrier to accessing potential treatments and vaccines, and the focus for now is on emergency measures to find health solutions.
The Politicization Of The US Patent System 25/08/2014 by Intellectual Property Watch 1 Comment The Washington Post story, How patent reform’s fraught politics have left USPTO still without a boss (July 30), is a vivid account of how patent reform has divided the US economy, preempting a possible replacement for David Kappos who stepped down 18 months ago. The division is even bigger than portrayed. Universities have lined up en masse to oppose reform, while main street businesses that merely use technology argue for reform. Reminiscent of the partisan divide that has paralyzed US politics, this struggle crosses party lines and extends well beyond the usual inter-industry debates. Framed in terms of combating patent trolls through technical legal fixes, there lurks a broader economic concern – to what extent ordinary retailers, bank, restaurants, local banks, motels, realtors, and travel agents should bear the burden of defending against patents as a cost of doing business, writes Brian Kahin.
Legal Analysis Of CJEU Hearing On Spain’s Case Against Unitary Patent 05/08/2014 by Intellectual Property Watch Leave a Comment A new legal analysis looks at the 1 July oral hearing of the European Court of Justice (CJEU) on Spain’s nullity actions against the regulations on the “unitary patent” and its language regime.
Special Report: Update On Implementation Of The EU Patent Package 25/07/2014 by Maëli Astruc for Intellectual Property Watch Leave a Comment Significant progress has been made in the implementation of the European regulation to establish a European unitary patent and an international treaty which sets up a unified patent court. Given the loaded agenda for the coming year, it seems that a lot of work remains to be done. Meanwhile, an ongoing proceeding before the Court of Justice of the European Union (CJEU) initiated by Spain could bring down the whole system, according to sources.
New Medicines Patent Pool-Gilead Agreement For New HIV Drug In 112 Countries 24/07/2014 by Catherine Saez, Intellectual Property Watch Leave a Comment The Medicines Patent Pool today announced a new licensing agreement with Gilead Sciences for a new treatment still undergoing clinical trials. This agreement is expected to allow Chinese and Indian generic manufacturers to provide low-cost versions of the drug in 112 low-and middle-income countries.
Medicines Patent Pool Signs 7 New Sub-Licences For Generic HIV Drugs 18/07/2014 by William New, Intellectual Property Watch 1 Comment The Medicines Patent Pool has announced seven new sub-licensing agreements to produce generic HIV medicines in order to make more affordable versions available to developing countries.
Human Eggs That Can’t Develop Into Human Beings Should Be Patentable, EU High Court Advisor Says 17/07/2014 by Dugie Standeford for Intellectual Property Watch 2 Comments Unfertilised human eggs that can’t develop into human beings are generally not “human embryos” within the meaning of the EU directive on the legal protection of biotechnological inventions, a 17 July European Court of Justice Advocate General opinion said. The opinion is good news for researchers into stem cell therapies, said a member of the industry group IP Federation, who added he hopes it will be upheld by the ECJ. But one biotech civil society member said the ruling, if it stands, could be abused.
US High Court Shuts Door On Many Software Patents 20/06/2014 by Steven Seidenberg for Intellectual Property Watch 1 Comment Software patents have become a major problem in the United States. These patents are often so vague and broad, they are hindering innovation and economic growth, according to many businesses, economists, and patent experts. But thanks to a ruling yesterday by the United States Supreme Court,the ranks of software patents may soon be decimated.
Access To Vaccines, Patents Growing Concerns, Panellists Say 10/06/2014 by Catherine Saez, Intellectual Property Watch Leave a Comment LYON, France – At the Biovision life science forum looking into translating innovation into health-related solutions last week, a panel of speakers shared their experience about the global access to vaccines. Although vaccination coverage is on the rise and intellectual property has not been a major concern in the past decade for vaccines, patents may well become a barrier in the future, panellists said.
Patentees Suffer Double Loss At US Supreme Court 02/06/2014 by Steven Seidenberg for Intellectual Property Watch Leave a Comment The United States Supreme Court issued two important patent law decisions recently. Both unanimous rulings provided bad news to patentees, particularly patent trolls.